Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Salivary Gland Neoplasms × neratinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1 Salivary Gland Neoplasms 1 Rare Tumour 1 HER2-positive Breast Cancer 1 Cholangiocarcinoma 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasms 1 Breast Cancer With Brain Metastasis 1 Brain Neoplasms 1

Interventions

neratinib 1 RC48 antibody 1 Observation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06519110 2024-07-25

CVL009-C2001

Convalife (Shanghai) Co., Ltd.

Phase 2 Not yet recruiting

GastrointestinalGynecologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Salivary Gland Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡